| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |